Literature DB >> 24478404

Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease.

Moritz Jansson1, Marcus Beissner, Richard Odame Phillips, Kossi Badziklou, Ebekalisai Piten, Issaka Maman, Fred Stephen Sarfo, Kristina Lydia Huber, Agata Rhomberg, Dominik Symank, Magdalena Wagner, Franz Wiedemann, Jörg Nitschke, Abiba Banla Kere, Karl-Heinz Herbinger, Ohene Adjei, Thomas Löscher, Gisela Bretzel.   

Abstract

This study evaluates a novel assay for detecting rifampin resistance in clinical Mycobacterium ulcerans isolates. Although highly susceptible for PCR inhibitors in 50% of the samples tested, the assay was 100% M. ulcerans specific and yielded >98% analyzable sequences with a lower limit of detection of 100 to 200 copies of the target sequence.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24478404      PMCID： PMC3993512          DOI： 10.1128/JCM.03119-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Novel polymorphic region of the rpoB gene containing Mycobacterium species-specific sequences and its use in identification of mycobacteria.

Authors:  Hyeyoung Lee; Hye-Eun Bang; Gill-Han Bai; Sang-Nae Cho
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.

Authors:  Wei Li; Masanori Matsuoka; Masanori Kai; Pratibha Thapa; Saraswoti Khadge; Deanna A Hagge; Patrick J Brennan; Varalakshmi Vissa
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana.

Authors:  Marcus Beissner; Nana-Yaa Awua-Boateng; William Thompson; Willemien A Nienhuis; Erasmus Klutse; Pius Agbenorku; Joerg Nitschke; Karl-Heinz Herbinger; Vera Siegmund; Erna Fleischmann; Ohene Adjei; Bernhard Fleischer; Tjip S van der Werf; Thomas Loscher; Gisela Bretzel
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

4.  Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays.

Authors:  T R Gingeras; G Ghandour; E Wang; A Berno; P M Small; F Drobniewski; D Alland; E Desmond; M Holodniy; J Drenkow
Journal:  Genome Res       Date:  1998-05       Impact factor: 9.043

5.  Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB).

Authors:  B J Kim; S H Lee; M A Lyu; S J Kim; G H Bai; G T Chae; E C Kim; C Y Cha; Y H Kook
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples.

Authors:  Janet A M Fyfe; Caroline J Lavender; Paul D R Johnson; Maria Globan; Aina Sievers; Joseph Azuolas; Timothy P Stinear
Journal:  Appl Environ Microbiol       Date:  2007-05-25       Impact factor: 4.792

7.  Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.

Authors:  Laurent Marsollier; Nadine Honoré; Pierre Legras; Anne Lise Manceau; Henri Kouakou; Bernard Carbonnelle; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

8.  Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010.

Authors:  Gisela Bretzel; Kristina Lydia Huber; Basil Kobara; Marcus Beissner; Ebekalisai Piten; Karl-Heinz Herbinger; Franz Xaver Wiedemann; Komi Amekuse; Abiba Banla Kere; Kerstin Helfrich; Erna Fleischmann; Thomas Löscher; Adolf Diefenhardt; Jörg Nitschke
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

9.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

10.  Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay.

Authors:  Marcus Beissner; Dominik Symank; Richard Odame Phillips; Yaw Ampem Amoako; Nana-Yaa Awua-Boateng; Fred Stephen Sarfo; Moritz Jansson; Kristina Lydia Huber; Karl-Heinz Herbinger; Florian Battke; Thomas Löscher; Ohene Adjei; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28
View more
  8 in total

1.  In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis.

Authors:  Sushim Kumar Gupta; Michel Drancourt; Jean-Marc Rolain
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

Review 2.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

3.  Genotyping Tools for Mycobacterium ulcerans-Drawbacks and Future Prospects.

Authors:  Charles A Narh; Lydia Mosi; Charles Quaye; Samuel Ck Tay; Bassirou Bonfoh; Dziedzom K de Souza
Journal:  Mycobact Dis       Date:  2014-05-05

4.  Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana.

Authors:  Enid Owusu; Mercy Jemima Newman; Nana Konama Kotey; Amos Akumwena; Elizabeth Bannerman
Journal:  Int J Microbiol       Date:  2016-12-14

5.  Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region.

Authors:  Issaka Maman; Tchadjobo Tchacondo; Abiba Banla Kere; Ebekalisai Piten; Marcus Beissner; Yiragnima Kobara; Komlan Kossi; Kossi Badziklou; Franz Xaver Wiedemann; Komi Amekuse; Gisela Bretzel; Damintoti Simplice Karou
Journal:  BMC Infect Dis       Date:  2018-01-19       Impact factor: 3.090

6.  Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo.

Authors:  Issaka Maman; Tchadjobo Tchacondo; Abiba Banla Kere; Marcus Beissner; Kossi Badziklou; Ekanao Tedihou; Edith Nyaku; Komi Amekuse; Franz Xaver Wiedemann; Damintoti Simplice Karou; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2018-05-21

7.  Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test.

Authors:  Marcus Beissner; Richard Odame Phillips; Florian Battke; Malkin Bauer; Kossi Badziklou; Fred Stephen Sarfo; Issaka Maman; Agata Rhomberg; Ebekalisai Piten; Michael Frimpong; Kristina Lydia Huber; Dominik Symank; Moritz Jansson; Franz Xaver Wiedemann; Abiba Banla Kere; Karl-Heinz Herbinger; Thomas Löscher; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2015-11-13

8.  Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.

Authors:  Richard O Phillips; Jérôme Robert; Kabiru Mohamed Abass; William Thompson; Fred Stephen Sarfo; Tuah Wilson; Godfred Sarpong; Thierry Gateau; Annick Chauty; Raymond Omollo; Michael Ochieng Otieno; Thaddaeus W Egondi; Edwin O Ampadu; Didier Agossadou; Estelle Marion; Line Ganlonon; Mark Wansbrough-Jones; Jacques Grosset; John M Macdonald; Terry Treadwell; Paul Saunderson; Albert Paintsil; Linda Lehman; Michael Frimpong; Nanaa Francisca Sarpong; Raoul Saizonou; Alexandre Tiendrebeogo; Sally-Ann Ohene; Ymkje Stienstra; Kingsley B Asiedu; Tjip S van der Werf
Journal:  Lancet       Date:  2020-03-12       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.